Your browser doesn't support javascript.
loading
Localizing pharmaceuticals manufacturing and its impact on drug security in Saudi Arabia.
Tawfik, Essam A; Tawfik, Abdulkader F; Alajmi, Areej M; Badr, Moutaz Y; Al-Jedai, Ahmed; Almozain, Nada H; Bukhary, Haitham A; Halwani, Abdulrahman A; Al Awadh, Saeed A; Alshamsan, Aws; Babhair, Salim; Almalik, Abdulaziz M.
Afiliação
  • Tawfik EA; National Center of Biotechnology, Life Science and Environment Research Institute, King Abdulaziz City for Science and Technology (KACST), Riyadh, Saudi Arabia.
  • Tawfik AF; Drug Dimension Company, Riyadh, Saudi Arabia.
  • Alajmi AM; National Center of Biotechnology, Life Science and Environment Research Institute, King Abdulaziz City for Science and Technology (KACST), Riyadh, Saudi Arabia.
  • Badr MY; Department of Pharmaceutics, College of Pharmacy, Umm Al-Qura University, Makkah, Saudi Arabia.
  • Al-Jedai A; Therapeutic Affairs, Ministry of Health, Riyadh, Saudi Arabia.
  • Almozain NH; College of Pharmacy, College of Medicine, Alfaisal University, Riyadh, Saudi Arabia.
  • Bukhary HA; Inpatient Department, Pharmaceutical Services Department, Prince Sultan Military Medical City, Riyadh, Saudi Arabia.
  • Halwani AA; Department of Pharmaceutics, College of Pharmacy, Umm Al-Qura University, Makkah, Saudi Arabia.
  • Al Awadh SA; Pharmaceutics Department, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia.
  • Alshamsan A; Saudi Food and Drug Authority, Drug Sector, Riyadh, Saudi Arabia.
  • Babhair S; Nanobiotechnology Unit, Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
  • Almalik AM; Five Dimensions for Consultation Company, Riyadh, Saudi Arabia.
Saudi Pharm J ; 30(1): 28-38, 2022 Jan.
Article em En | MEDLINE | ID: mdl-35145343
Local production of pharmaceuticals plays a vital role in maintaining resilience of national healthcare systems, especially when it comes to facilitating access to needed medicines and decreasing exposure to imports and international supply chains. Pharma is a research-intensive industry and the systemic lack of governance and support to R&D activities in this sector, among other host of related issues such as unsupportive regulatory regimes and human resources capacity limitations, is one of the major impediments to the diversifying of locally produced pharmaceuticals portfolio. In this review, an overview of the current pharmaceutical production system in Saudi Arabia, its major challenges, and proposed remedies to address them will be highlighted.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article